This toolkit contains resource links and templates to ensure your company has priority access to the vaccine.

Vaccine Prioritization for the Food Industry

The U.S. Centers for Disease Control and Prevention (CDC) announced in December 2020 that its Advisory Committee on Immunization Practices (ACIP) reviewed and voted on vaccine prioritization for the food industry in “phase 1b,” including the frozen food industry. 

For more information on when the vaccine will be available, visit the CDC’s vaccine page. It’s now up to governors to work with their state health departments to allocate the COVID-19 vaccines. 

AFFI is working with federal and state policymakers to ensure the frozen food industry workforce are prioritized for the vaccine.

The U.S. Centers for Disease Control and Prevention (CDC) provides revised Public Health Recommendations for Fully Vaccinated People (updated July 28, 2021

    1. To maximize protection from the Delta variant and prevent possibly spreading it to others, wear a mask in public indoors settings in areas of high transmission.

    2. Wearing a mask is most important if you have a weakened immune system or if, because of your age or an underlying medical condition, you are at increased risk for severe disease, or if someone in your household has a weakened immune system, is at increased risk for severe disease, or is unvaccinated. If this applies to you or your household, you might choose to wear a mask regardless of the level of transmission in your area.

    3. Fully vaccinated people who have a known exposure to someone with suspected or confirmed COVID-19 should be tested 3-5 days after exposure and wear a mask in public indoor settings for 14 days or until they receive a negative test result.

    4. Fully vaccinated individuals can refrain from routine testing but should get tested if experiencing COVID-19 symptoms, Individuals should isolate for ten days if they have tested positive or are experiencing COVID-19 symptoms.

    5. Fully vaccinated people can resume domestic travel and refrain from testing before or after travel or self-quarantine after travel.

AFFI’s Vaccine Toolkit

Open dialogue, engagement and effective communication is important to address the skepticism around vaccines that exists among many people and in many communities. Access AFFI’s vaccine toolkit below to communicate the value of the COVID-19 vaccine to your workforce and stay abreast of the most recent federal guidance.

CDC COVID-19 Vaccine Communication Toolkit for Essential Workers

CDC has provided a COVID-19 Vaccine Communication Toolkit for Essential Workers to help employers educate their essential workers about the coronavirus vaccine. The toolkit contains a variety of resources like:

  • key messages,
  • an educational slide deck,
  • FAQs,
  • customizable posters/flyers,
  • newsletter content,
  • a plain language vaccine factsheet (available in several different languages),
  • a template letter for employees
  • social media content, and vaccination sticker templates

Access the Toolkit

COVID-19 Vaccine Education and Equity Project

AFFI is supporting the COVID-19 Vaccine Education and Equity Project to help educate the public on vaccines. The effort was created and is supported by much of the healthcare community. The group has resources available in English and Spanish that can be shared with your employees to help build confidence in the process and ultimately raise awareness around the importance of COVID-19 vaccination. For more information and to access the resources, click here.


Access the Resources

COVID-19 Vaccines Authorized for Emergency Use

Visit this FDA page for information for the food and agriculture sector about the safety and effectiveness of COVID-19 vaccines authorized for emergency use by the FDA.

The U.S. Equal Employment Opportunity Commission (EEOC) outlines how the availability of COVID-19 vaccinations apply to various laws, including legal requirements of the Americans with Disabilities Act (ADA), Title VII of the Civil Rights Act of 1964, and the Genetic Information Nondiscrimination Act (GINA). This includes issues pertaining to medical pre-screening questions and employer accommodations for those unable to receive a vaccination. 

Click here and navigate to points K.5-K.7 to understand what to do when an employer requires vaccination and an employee indicates they are unable to receive one.

For Assistance Contact:

Dr. Donna Garren

Executive Vice President of Science and Policy

Dr. Lory Reveil

Senior Director of Scientific and Regulatory Affairs

Dr. Sanjay Gummalla

Senior Vice President of Scientific Affairs

The voluntary industry guidance on this website (“Industry Guidance”) is based on recommendations received from a variety of sources, including federal agencies, state health authorities, and industry advisors. As recommended practices continue to evolve, guidance on these issues also may have been issued by federal agencies such as the Centers for Disease Control (CDC), the U.S. Department of Labor, state and local authorities, and others subsequent to the formulation of this Industry Guidance.  For this reason, in addition to considering this Industry Guidance, readers are encouraged to review any and all updated guidance from either industry or governmental authorities, as well as any guidance that may be issued in the future, as it is expected that recommended practices will continue to evolve. Readers should also check this website for any updated versions of this Industry Guidance.  

AFFI disclaims all (1) express and implied warranties and (2) any liability that may allegedly result as a result of reliance on this Industry Guidance.  

Readers are also encouraged to exercise their best judgment in considering whether, due to their particular individual circumstances, it would be reasonable to implement additional measures to further reduce the risks related to COVID-19.  Readers are further encouraged to consider any and all additional authoritative resources and advice.

  • Scroll to Top